Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid in Pediatric Idiopathic Scoliosis Surgery
NCT07581457Recruiting
- Sponsor
- Poznan University of Medical Sciences
- Start
- May 2026
- Primary completion
- May 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of tranexamic acid in Idiopathic scoliosis (IS) (3 arms), sponsored by Poznan University of Medical Sciences. Primary endpoint: Total Blood Loss at 24 hours. Started May 2026; status: recruiting.
02
Drugs
tranexamic acid
03
Conditions
Idiopathic scoliosis (IS)
Beyond the preview
Go deeper on NCT07581457.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07581457.